About Haelixa
Haelixa is a company based in Zurich (Switzerland) founded in 2015 was acquired by Clariant in September 2018. Haelixa has raised $2.49 million across 5 funding rounds from investors including Clariant, Zurcher Kantonalbank and European Union. Haelixa offers products and services including DNA Marking Technology. Haelixa operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Zurich, Switzerland
-
Sectors
HealthcareRetail Energy & Utilities
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Haelixa
Haelixa offers a comprehensive portfolio of products and services, including DNA Marking Technology.
Uses DNA to track and verify material origins in supply chains.
People of Haelixa
Unlock access to complete
Funding Insights of Haelixa
Haelixa has successfully raised a total of $2.49M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.37 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Haelixa
Haelixa has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Clariant, Zurcher Kantonalbank and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
University backed startup accelerator
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Haelixa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haelixa
Investment portfolio details for Haelixa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Haelixa
Detailed financials for Haelixa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haelixa Comparisons
Peer comparison for Haelixa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Haelixa
Haelixa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Haelixa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haelixa
Complete news archive for Haelixa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haelixa
Haelixa was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Haelixa is headquartered in Zurich, Switzerland.
Haelixa is a funded company, having raised a total of $2.49M across 5 funding rounds to date.
Haelixa was founded in 2015 in Zurich, Switzerland. DNA-based tracers are offered for the energy industry, enabling fluid tracking and monitoring of parameters such as temperature, light, pH, and oxidants in subsurface environments. Encapsulated DNA sequences provide unique identification at parts-per-trillion levels, supporting reservoir characterization and product authentication. Operations focus on exploration, quality control, and liability management within harsh conditions.
Haelixa's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Haelixa offers DNA Marking Technology.
Haelixa has 6 investors. Key investors include Clariant, Zurcher Kantonalbank, European Union, Verve Ventures, and Venture Kick.